Late July 2026: Sika opens its largest U.S. mortar plant and acquires Akkim; IndexBox forecasts PCE demand to accelerate at 5.8% CAGR through 2035; Saint-Gobain signs definitive Xypex deal; U.S. cellulose ether prices rise 1.00% on tight Chinese supply.
Saint-Gobain’s Xypex acquisition plus the completed Fosroc close reshape the crystalline waterproofing map, US cellulose ether edges up 1.00% on Chinese export constraints, bio-based admixtures reach a regulatory inflection in Japan, Germany and California, and the global PCE industry passes 15 million tons of active capacity with low-alkali grades taking 60% share.
Mid-summer 2026 industry check-in: BASF closes its EUR 7.7B coatings divestment to refocus on construction chemistry, the Hassan et al. critical review ranks the four self-healing mechanisms in 3D-printed concrete, RDP demand stays Asia-led with bio-attributed VAE as the new differentiator, and the Thai TCMA mobile CCUS pilot plus India’s USD 2B budget test the limits of carbon-capture execution.
As the H2 2026 construction season opens, three structural forces are reshaping the construction chemicals industry: a demand recalibration across regions as CBAM definitive regime and divergent PMI readings sort winners from laggards; the maturation of bio-based PCE superplasticizers; and the rapid crystallization race in waterproofing admixtures. Here’s what buyers, formulators, and specifiers need to know.
LC3 cement reaches 35 commercial plants worldwide, PCE innovation advances with photo-initiated synthesis and phosphonate anchors, industry consolidation intensifies with Saint-Gobain EUR 6B combine and Sika CHF 180M synergies, Holcim CCUS enters execution phase targeting 1.1Mt CO2 capture, and cellulose ether pharma-grade premium accelerates with low-nitrosamine HPMC.
Construction chemicals H2 2026: cellulose ether premium-value shift, RDP steady 8.6% CAGR growth, 3DCP self-healing mechanisms crossing the industrial threshold, and ETICS market crossing USD 19.3 billion at 6.85% CAGR through 2032.
BASF CoreShift launches the largest optimization program in company history, targeting 20% cost savings by 2029 and selling its silicates business to PQ. CBAM’s definitive regime reorders cellulose ether trade flows across three regions. CCUS faces a credibility gap as two flagship European projects stall while Asia accelerates. Geopolymer cement crosses USD 3.2 billion at 10.7% growth. PCE innovation pivots toward LC3 compatibility and 3DCP rheology. VAE redispersible powder market reaches USD 1.23 billion with sustainability transformation.
As the construction chemicals industry turns the corner into H2 2026, four under-the-radar shifts are quietly reshaping how formulators, contractors, and procurement teams should plan. Cellulose ether prices ease on propylene oxide cost relief, bio-based RDP graduates from pilot to commercial supply, 3DCP-ready admixture systems cross the credibility threshold, and crystalline capillary waterproofing admixtures emerge as a self-healing technology ready to leave the lab. A practical briefing for sourcing, specification, and R&D teams.
Sika’s Q1 2026 results reveal market share gains despite muted global construction, cellulose ether prices show dramatic regional divergence (China -5.70%, Europe +4.23%, US +0.72%), and RDP innovation accelerates with self-healing mortar, LC3-compatible formulations, and nano-reinforced systems reshaping H2 2026.
Redispersible polymer powder demand hits USD 1.97 billion in 2026 as APAC captures 45.55% share, the EU moves to mandate lifecycle GWP reporting for all new buildings by 2030, waterproofing admixtures ride an 8.3% CAGR to USD 15.6 billion by 2035, and three independent self-healing concrete breakthroughs converge on commercial viability.
